Details for New Drug Application (NDA): 020988

✉ Email this page to a colleague

« Back to Dashboard

NDA 020988 describes PROTONIX IV, which is a drug marketed by Wyeth Pharms and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the PROTONIX IV profile page.

The generic ingredient in PROTONIX IV is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.

Summary for 020988

Tradename:	PROTONIX IV
Applicant:	Wyeth Pharms
Ingredient:	pantoprazole sodium
Patents:	3
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020988

Mechanism of Action	Proton Pump Inhibitors

Suppliers and Packaging for NDA: 020988

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988	NDA	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	0008-0923	0008-0923-51	1 VIAL in 1 CARTON (0008-0923-51) > 10 mL in 1 VIAL
PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988	NDA	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.	0008-0923	0008-0923-55	10 CARTON in 1 PACKAGE (0008-0923-55) > 1 VIAL in 1 CARTON > 10 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INTRAVENOUS			Strength	EQ 40MG BASE/VIAL
Approval Date:	Mar 22, 2001	TE:	AP	RLD:	Yes
Patent:	See Plans and Pricing	Patent Expiration:	May 17, 2022	Product Flag?		Substance Flag?		Delist Request?
Patent:	See Plans and Pricing	Patent Expiration:	May 17, 2022	Product Flag?		Substance Flag?		Delist Request?
Patent:	See Plans and Pricing	Patent Expiration:	May 17, 2022	Product Flag?		Substance Flag?		Delist Request?

Expired US Patents for NDA 020988

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Wyeth Pharms	PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988-001	Mar 22, 2001	See Plans and Pricing	See Plans and Pricing
Wyeth Pharms	PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988-001	Mar 22, 2001	See Plans and Pricing	See Plans and Pricing
Wyeth Pharms	PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988-001	Mar 22, 2001	See Plans and Pricing	See Plans and Pricing
Wyeth Pharms	PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988-001	Mar 22, 2001	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.